Home News Maps Astrology Recipes Travel

Harvest One Launches New Satipharm CBD Oil

VANCOUVER: Harvest One Cannabis Inc. (Harvest One or the Company) (TSXV: HVT; OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm Ltd. (Satipharm) announced it has expanded its product portfolio with the launch of CBD oil, now available online at www.satipharm.com. Brick and mortar distribution will follow with major retailers throughout Europe.

The new European oils program has begun with a Lemon & Lime flavoured CBD oil. Satipharm expects to expand this program with more varieties in the coming months. Satipharm CBD oils join the existing CBD Gelpell capsules, already available across Europe online and in 1,800 stores across the UK and Ireland. All of Satipharm's products in Europe are EU GMP certified to ensure the highest standards.

The Satipharm Lemon & Lime CBD oil was specifically formulated to address three major concerns from consumers, which are taste, GMP certification, and reliable dosage.

Product innovation is essential to building our brands. Our new CBD oil illustrates continued movement by Harvest One towards our strategy of building health, wellness, and self-care brands around the world, said Grant Froese, Chief Executive Officer of Harvest One. Customers can have the same confidence in new Satipharm CBD oils as they do in our existing Satipharm CBD Gelpell already on the market across Europe.

Further to Harvest One's press release dated June 21, 2019 (See SEDAR for full disclosure) in respect to a shares-for-services agreement, the Company has issued 131,710 common shares at a price of $0.57 per share.

Like This Article?
Harvest One Launches New Satipharm CBD Oil

© 2001-2019 newkerala.com | Support